Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/10071
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorRIGO, J.; JACOBS, N.-
dc.contributor.authorLANGERS, Inge-
dc.date.accessioned2009-12-14T08:56:59Z-
dc.date.available2009-12-14T08:56:59Z-
dc.date.issued2009-
dc.identifier.urihttp://hdl.handle.net/1942/10071-
dc.description.abstractCervical cancer is caused by infection with high-risk human papillomaviruses (HPV). Recently, prophylactic vaccines based on HPV virus like particles (VLP) have become available. These vaccines are efficient to HPV-16 and HPV-18 infections, but not against established infection. Previous studies have shown that HPV-VLP were able to activate dendritic cells (DC). NK cell activation in vaccination protocols has been rarely studied; we studied the effect of VLP on the interaction between DC and NK cells in an autologous setting. We confirmed previous studies and when we co-cultured VLP activated DC and NK cells, we observed an increase in cell surface expression of CD69. This up-regulation was also accompanied by increased IFN-' secretion in the presence of VLP. Interestingly, NK cells seemed to further activate DC in the presence of VLP as shown by up-regulation of HLA-DR, CD86 and CD80 on DC. Moreover we found that NK cells synergise with VLP in modulating DC cytokine secretion, sinc-
dc.format.mimetypeApplication/pdf-
dc.languagenl-
dc.publishertUL Diepenbeek-
dc.titleCross talk between dendritic and natural killer cells in the presence of vaccine agent against cervical cancer-
dc.typeTheses and Dissertations-
local.format.pages40-
local.bibliographicCitation.jcatT2-
dc.description.notes2de masterjaar in de biomedische wetenschappen - klinische moleculaire wetenschappen-
local.type.specifiedMaster thesis-
dc.bibliographicCitation.oldjcat-
item.contributorLANGERS, Inge-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
item.fullcitationLANGERS, Inge (2009) Cross talk between dendritic and natural killer cells in the presence of vaccine agent against cervical cancer.-
Appears in Collections:Master theses
Files in This Item:
File Description SizeFormat 
04221032008249c.pdf1.09 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.